Tibet Rhodiola Pharmaceutical Holding Co Financial Flexibility Index
Tibet Rhodiola Pharmaceutical Holding Co financial flexibility index. Tibet Rhodiola Pharmaceutical Holding Co (600211) has a Financial Flexibility Index of 0.14x as of December 2025. Free cash flow of CN¥302.85 Million (operating CF CN¥297.86 Million minus capex CN¥4.98 Million) represents 0% of total liabilities (CN¥2.10 Billion). See 600211 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)
Financial flexibility index of Tibet Rhodiola Pharmaceutical Holding Co from 1999 to 2025. Historical Financial Flexibility Index trend for Tibet Rhodiola Pharmaceutical Holding Co across 27 annual periods. Check how high is Tibet Rhodiola Pharmaceutical Holding Co's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Tibet Rhodiola Pharmaceutical Holding Co Financial Flexibility Index by Year (1999–2025)
Tibet Rhodiola Pharmaceutical Holding Co financial flexibility index by year from 1999 to 2025. Year-by-year free cash flow to debt coverage for Tibet Rhodiola Pharmaceutical Holding Co. For the full cash flow conversion analysis, see 600211 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | CN¥1.04 Billion | CN¥1.03 Billion | CN¥2.10 Billion | ▼ -61.8% |
| 2024 | 1.30x | CN¥1.03 Billion | CN¥994.79 Million | CN¥795.23 Million | ▲ +42.7% |
| 2023 | 0.91x | CN¥1.10 Billion | CN¥1.08 Billion | CN¥1.21 Billion | ▲ +3.5% |
| 2022 | 0.88x | CN¥939.34 Million | CN¥837.38 Million | CN¥1.07 Billion | ▲ +28.5% |
| 2021 | 0.68x | CN¥792.11 Million | CN¥366.53 Million | CN¥1.16 Billion | ▼ -62.5% |
| 2020 | 1.82x | CN¥649.46 Million | CN¥428.17 Million | CN¥355.91 Million | ▲ +8.6% |
| 2019 | 1.68x | CN¥538.59 Million | CN¥489.59 Million | CN¥320.44 Million | ▲ +47.8% |
| 2018 | 1.14x | CN¥312.58 Million | CN¥289.22 Million | CN¥274.89 Million | ▼ -53.7% |
| 2017 | 2.46x | CN¥699.43 Million | CN¥91.46 Million | CN¥284.64 Million | ▲ +1443.8% |
| 2016 | 0.16x | CN¥259.85 Million | CN¥250.21 Million | CN¥1.63 Billion | ▼ -75.7% |
| 2015 | 0.66x | CN¥144.59 Million | CN¥133.93 Million | CN¥220.43 Million | ▲ +465.5% |
| 2014 | -0.18x | CN¥-113.48 Million | CN¥-141.40 Million | CN¥632.26 Million | ▼ -142.3% |
| 2013 | 0.42x | CN¥313.34 Million | CN¥279.22 Million | CN¥738.26 Million | ▲ +221.9% |
| 2012 | 0.13x | CN¥60.62 Million | CN¥56.20 Million | CN¥459.72 Million | ▲ +296.4% |
| 2011 | 0.03x | CN¥14.40 Million | CN¥12.09 Million | CN¥432.93 Million | ▲ +205.5% |
| 2010 | 0.01x | CN¥4.48 Million | CN¥1.90 Million | CN¥411.28 Million | ▼ -77.6% |
| 2009 | 0.05x | CN¥21.59 Million | CN¥17.88 Million | CN¥443.70 Million | ▲ +2.0% |
| 2008 | 0.05x | CN¥26.26 Million | CN¥21.46 Million | CN¥550.51 Million | ▲ +2997.5% |
| 2007 | 0.00x | CN¥-918.00K | CN¥-18.30 Million | CN¥557.68 Million | ▼ -101.6% |
| 2006 | 0.11x | CN¥49.53 Million | CN¥33.63 Million | CN¥470.56 Million | ▲ +73.1% |
| 2005 | 0.06x | CN¥25.99 Million | CN¥18.92 Million | CN¥427.37 Million | ▼ -53.1% |
| 2004 | 0.13x | CN¥44.35 Million | CN¥26.90 Million | CN¥341.74 Million | ▼ -38.9% |
| 2003 | 0.21x | CN¥70.08 Million | CN¥47.20 Million | CN¥329.82 Million | ▼ -50.5% |
| 2002 | 0.43x | CN¥135.00 Million | CN¥32.85 Million | CN¥314.23 Million | ▼ -8.9% |
| 2001 | 0.47x | CN¥95.19 Million | CN¥15.47 Million | CN¥201.82 Million | ▼ -57.2% |
| 2000 | 1.10x | CN¥139.00 Million | CN¥20.55 Million | CN¥126.01 Million | ▼ -21.3% |
| 1999 | 1.40x | CN¥65.50 Million | CN¥2.25 Million | CN¥46.73 Million | — |